The global pandemic of the novel corona virus (COVID-19/SARS CoV-2 strain) is spreading rapidly, mutating and has so far affected numerous lives since its outburst in December, 2019 most likely from the Wuhan province in the People’s Republic of China and thereafter transmitted to several countries of the world with an estimated disease burden of casualties rising to more than ten thousand worldwide as of date and leaving more than 300,000 individuals affected worldwide.

References

1. Savarino A., et al. “Effects of chloroquine on viral infections: an old drug against today's diseases?” Lancet Infectious Diseases 11 (2003): 722-727.
2. Yan Y., et al. “Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model”. Cell Research2 (2013): 300-302.
3. Lu H. “Drug treatment options for the 2019-new coronavirus (2019-nCoV)”. BioScience Trends 1 (2020): 69-71.

Citation

Citation: Raja Chakraverty. “Status of Newer Emerging Therapeutic Strategies in the Pipeline for Mitigation of the SARS-CoV2 Infection: Some Challenges and Introspects".Acta Scientific Pharmacology 1.4 (2020): 18.

Copyright

Copyright: © 2020 Raja Chakraverty. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.